Novartis’ new therapy for neovascular age-related macular degeneration (nAMD) has advanced part-way through the European regulatory process after winning the...
Read moreInconsistent or ineffective age-related macular degeneration (AMD) treatments might be solved by an easy solution, according to new research from...
Read moreMelbourne-based biotech company Opthea has announced it has secured commitments from both Australian and international investors for an additional $50...
Read moreMultinational biotech company Biogen has proposed a deal worth up to US$310 million (AU$453 m) to supply biosimilar treatments of...
Read moreAnti-vascular endothelial growth factor (anti-VEGF) drugs have been identified in breast milk, prompting warnings from the researchers that the use...
Read moreOptometrists performing intravitreal injections is one of several key issues to be addressed by a newly formed Optometry Australia (OA)...
Read moreThe University of Melbourne is recruiting optometrists to test new clinical tools, as well as an auditing system, it has...
Read moreNovartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the...
Read moreThe Lions Eye Institute (LEI) has signed a commercial partnership that will combine its antisense gene therapy for a leading cause of...
Read moreControversial plans to dramatically reduce the rebate for intravitreal injections and also allow non-ophthalmologists to perform the procedure have divided...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited